Randomized, Double Blind, Placebo-Controlled Clinical Trial Evaluating Ramelteon in the Prevention of Delirium
Phase of Trial: Phase IV
Latest Information Update: 31 Mar 2017
At a glance
- Drugs Ramelteon (Primary)
- Indications Delirium
- Focus Therapeutic Use
- 28 Mar 2017 Status changed from active, no longer recruiting to recruiting.
- 22 Feb 2017 Status changed from not yet recruiting to active, no longer recruiting.
- 07 Oct 2015 New trial record